drugset / Trial / NCT00299247

SP Resistance and Falciparum Malaria Transmission

NCT00299247

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to study resistance to current malaria treatments and affordable alternatives for uncomplicated malaria. Resistance occurs in areas where these treatments are used frequently. This study may help prevent future resistance. About 150 residents in Buenaventura, Colombia will participate. They will have uncomplicated malaria and they will be followed for 28 days after treatment. Physical exams and blood draws are included in study visits.

Timeline

Start
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject pyrimethamine Small molecule
Subject sulfadoxine Small molecule